Professional Documents
Culture Documents
• Acute infection
• Asymptomatic but positive HIV
• Persistent generalised lymphadenopathy
• AIDS (HIV related diseases)
o Constitutional diseases like weight loss, fever, diarrhoea
o Neurological diseases, dementia, neuropathy, myelopathy
o Opportunistic infections
o Malignancies. Kaposi's sarcoma, non-Hodgkin's lymphomas, primary cerebral lymphomas
o Other diseases attributable to HIV infection
After HIV infection, there is a time gap for the patient to become reactive to tests. This time gap is called
as "Window period". This period is variable. But during this period, the individual is infective.
Mode of Transmission
HIV mainly harbours in semen, genital secretions, blood, pus, sputum, saliva and other body fluids.
Management
Investigations
Treatment
Antiviral therapy: ,
o Nucleoside reverse transcriptase inhibitor (NRTI): Zidovudine, didanosine, abacavir,
lamivudine, stavudine.
o Non-nucleoside reverse transcriptase inhibitor (NNRTI) : Nevirapine, delavirdine. ,
Protease inhibitors: Ritonavir, indinavir, amprenavir.
Treatment of opportunistic infections.
Treatment of tumours
lmmunotherapy: , Alpha and gamma interferons. ,. Interleukins.
Bone marrow transplantation.
Anti-CD3 or IL-2 after HAART (Highly Active Anti-Retroviral Therapy).
Psychotherapy
Counselling of HIV patients and their families.
Life-expectancy after initial HIV infection is 8-1 O years.
Prevention